hers glp-1 Weight Loss Care for Women, Built to Last Hims & Hers Weight Loss
Description
GLP-1 prescriptions are based on medical evaluation and are not appropriate for all patients
However, the wording in Section 8.134 has been interpreted inconsistently around the verification of the suppliers sterility assurance
2024;109(3):e1267e79
The Food and Drug Administration (FDA) licensed Wegovy towards the end of December on the back of results from the OASIS 4 trial that showed the 25mg dose led to a mean weight loss of 16.6 percent
For example, 15 states cover Wegovy for obesity in the state employee plan, while 14 states cover it in Medicaid
